Emergency Hotlines: LANDLINE (+63) 2 911 – 8688

Senate supports DOH’s request to use a chunk of Dengvaxia refund  

by UNTV News   |   Posted on Wednesday, March 14th, 2018

FILE PHOTO: Senator Richard “Dick” Gordon

MANILA, Philippines — The Senate Blue Ribbon Committee supports the Department of Health’s (DOH) intention to use a portion of Sanofi Pasteur’s Dengvaxia refund.

Senator Richard Gordon has even filed a bill on the matter.

DOH wants to utilize P300,000 of the  P1.16-billion refund money for dengue kits and surveillance officers who will monitor the condition of Dengvaxia vaccinees.  — UNTV News & Rescue

Tags: , ,

Study affirms negative effects of Dengvaxia

by UNTV News and Rescue   |   Posted on Thursday, June 14th, 2018

The controversial anti-dengue vaccine, Dengvaxia

The New England Journal of Medicine published an article about the negative effects of the controversial anti-dengue vaccine, Dengvaxia to those who have not contracted the disease prior to inoculation.

According to the article entitled “Impact of Dengue Serostatus on Dengue Vaccine Safety and Efficacy,” the vaccine is effective in protecting the patient from a re-occurrence of dengue. However, to those without prior dengue infection, the vaccine is not recommended as it could lead to severe dengue.

The study focused on the analysis of the dengue vaccine manufactured by Sanofi Pasteur which is Dengvaxia. This means the research study is in conformity with the recommendation of the World Health Organization (WHO) in April that Dengvaxia should not be administered to children without prior exposure to dengue.

In November 2017, Sanofi Pasteur issued a warning saying there is very high possibility of contracting severe dengue if Dengvaxia is received by individuals without prior dengue infection.

Dengvaxia has been administered to nearly 800,000 children in the Philippines under the government’s Dengue immunization program. – UNTV News & Rescue

Tags: , ,

DOH proposes almost P1.5B for Dengvaxia assistance program

by UNTV News and Rescue   |   Posted on Wednesday, May 16th, 2018

FILE PHOTO: Department of Health Secretary Francisco Duque III


QUEZON CITY, Philippines – The House Committee on Appropriations discussed Wednesday, May 16, the proposed allotment of funds for Department of Health’s (DOH) Dengvaxia Assistance Program in accordance with House Bill Number 7449.

Present in the briefing were Health Secretary Francisco Duque III, Budget Secretary Benjamin Diokno, officials from the Public Attorney’s Office (PAO,) and parents of Dengvaxia vaccinees.

DOH presented before the committee its proposed allocation of the almost P1.5 billion fund which will be taken from the P1.61 billion refund from Sanofi Pasteur for the unused Dengvaxia vaccines.

In its proposal, DOH wants to use the said amount to provide medical assistance to Dengvaxia vaccinees (P84M); to fund DOH’s out-patient care package (P776.250M); to support the deployment of nurses for Health Education (P67.8M); proposed active case finding or profiling/navigation of vaccinees (P300M); and procurement of Dengvaxia medical kits (P270M)

However,committee chair Congressman Carlo Nograles opposed DOH’s appropriation of P270 million  for the purchase of medical kits citing that a larger fund is very much necessary to support the medical needs of Dengvaxia vaccinees.

Based on DOH’s records, there are at least 890,000 Dengvaxia vaccinees across the country. Parents of Dengvaxia vaccinees claimed during the briefing that more children injected with Dengvaxia are still unaccounted by health personnel.

In response to this, DOH appeals for the immediate approval of the budget proposal to deploy nurses who would do the profiling and monitoring of Dengvaxia vaccinees.

Budget Secretary Benjamin Diokno, meanwhile, suggested extending the use of funds preferably up to 2019 to accommodate requests from other agencies. — Rey Pelayo | UNTV News & Rescue

Tags: , ,

Over P22-M, spent for hospitalization of Dengvaxia vaccinees — DOH

by UNTV News   |   Posted on Saturday, April 14th, 2018

FILE PHOTO: A health worker injects Dengvaxia

MANILA, Philippines — The Department of Health’s (DOH) dengue adverse events surveillance has listed more than 3,000 dengvaxia vaccinees who became severely sick and were admitted to hospitals from 2016 to 2018.

More than 1,000 of them have tested positive for dengue. There are 65 recorded death cases and 13 of which had died of dengue infection.

The health department has spent more than P22.1 million for the medical services and hospitalization of vaccinees from different regions.

“Financial assistance to Dengvaxia vaccinees who got sick and were admitted to hospitals in the NCR, Central Luzon, Calabarzon and Cebu regions as additional support for our patients,” said Health Undersecretary Eric Domingo.

DOH is currently examining if the diseases which caused the death of the vaccinees have links to Dengvaxia and real effects of the said vaccine

“That’s why we collect the data from all of them so that when we take a look and we can see kung merong connection talaga (if there really is a connection) including of course doon sa fatalities natin (among the fatalities),” said the undersecretary.

The DOH expects the findings of the 17 cases of Dengvaxia vaccinees whose deaths are linked to Dengvaxia from the UP-PGH-DITF (Philippine General Hospital Dengue Investigative Task Force) to be released next week.

“The PGH-DITF is almost finalizing the report. Meron lang kasi alam kong isang pending case kasi may isang adult (There’s just one pending case involving an adult). Most of the members of the DITF initially were really pediatricians tapos nagkaroon tayo ng isang adult case iyong (then an adult case turned up, the) utility worker ng (of the)police, so this one they have to refer it to an internist,” said Domingo.

Meanwhile, health department is waiting for the approval of both houses of Congress for the use of P1.16  billion from the refund of Sanofi Pasteur for the Dengvaxia assistance program. — Aiko Miguel | UNTV News & Rescue

Tags: , ,